CTLA4 and cervical cancer: The polymorphisms of the fundamental immunosuppressive cytokine, cytotoxic T-lymphocyte antigen-4 (CTLA4, CD152), which terminates the T-cell response and prohibits T-cell activation, are associated with the risk of breast and cervical cancers (47).